Drug Name:
COLAZAL Rx
Generic Name and Formulations:
Balsalazide disodium (prodrug of mesalamine) 750mg; caps.
Company:
Bausch Health Companies Inc.
Therapeutic Use:
Indications for COLAZAL:
Mildly to moderately active ulcerative colitis.
Adult:
May swallow whole or sprinkle capsule contents into applesauce. 2.25g 3 times daily for 8 weeks; max 12 weeks.
Children:
May swallow whole or sprinkle capsule contents into apple sauce. <5yrs: not recommended. ≥5yrs: 2.25g 3 times daily or 750mg 3 times daily; max 8 weeks.
Warnings/Precautions:
Pyloric stenosis. Renal dysfunction. History of renal disease. Pregnancy (Cat.B). Nursing mothers.
Pharmacological Class:
Salicylate.
Adverse Reactions:
Headache, GI upset/pain, arthralgia, respiratory infection, insomnia, fatigue, anorexia, exacerbation of symptoms, pyrexia.
How Supplied:
Caps—280, 500
Neurology Advisor Articles
- Ajovy Injection Approved for Migraine Prevention in Adults
- Few With Acute Migraine Take Triptans, Many Discontinue the Drug
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Magnesium Has No Effect on Cognitive Outcomes Following Aneurysmal Subarachnoid Hemorrhage
- Incorporating Guidelines Into Clinical Practice: An Interview With Gary L. LeRoy, MD
- Combo Physical, Mental Activity Prevents Cognitive Decline
- Medicaid Expansion Linked to Gains in Insurance Coverage
- Folic Acid Supplementation May Protect Against Language Delay in AED-Exposed Children
Sign Up for Free e-newsletters
Check out what's trending
CME Focus
Tardive Dyskinesia Clinical Commentary
CME
1.00 Credits
Breaking the Vaccination Barrier in Adults
CME|CE
1.25 Credits